دورية أكاديمية

New Targets and New Mechanisms in Lung Cancer.

التفاصيل البيبلوغرافية
العنوان: New Targets and New Mechanisms in Lung Cancer.
المؤلفون: Carrizosa, Daniel R., Mileham, Kathryn F., Haggstrom, Daniel E., Brouse, Gregory M., Induru, Raghava, Kim, Edward S.
المصدر: Oncology (08909091); May2013, Vol. 27 Issue 5, p1-15, 15p
مستخلص: The article discusses the new forms of chemotherapy and new treatment targets in lung cancer. It is mentioned that gefitinib and erlotinib bind in reverse to the adenosine triphosphate (ATP) binding site of epidermal growth factor receptor (EGFR) tyrosine kinase which initiates signaling cascades. It states that Anaplastic Lymphoma Kinase (ALK) is identified in anaplastic large cell lymphoma patients. Types of chemotherapies including immunotherapy and cytotoxic chemotherapy is also described.
قاعدة البيانات: Complementary Index